Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening

Christelle Cabrol, Malwina A. Huzarska, Christopher Dinolfo et al. · 2009

Read Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening by Christelle Cabrol, Malwina A. Huzarska, Christopher Dinolfo et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005274.txt.

Description

Insulin-degrading enzyme, or IDE, breaks down both insulin and the amyloid protein tied to Alzheimer disease. Too little amyloid clearance may help drive Alzheimer disease, so switching IDE on is an attractive idea. Cabrol and colleagues screened for such switch-on compounds in PLOS ONE in 2009.

High-throughput screening tested many compounds for the power to raise IDE activity. The screen found small-molecule activators of the enzyme. First activators give chemists starting points for drugs that might help in both diabetes and Alzheimer disease, where IDE sits at a crossroads.

Catalog record

CREATORChristelle Cabrol, Malwina A. Huzarska, Christopher Dinolfo et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005274

Browse the full library · About the Tower of Babel